Jaguar Gene Therapy Closes $139 Million Series B Funding Co-led by Eli Lilly and Company and Deerfield Management
LAKE FOREST, Ill.--(BUSINESS WIRE)--Jaguar Gene Therapy today announced it has closed a $139 million Series B funding co-led by Eli Lilly and Company and Deerfield Management.
